Ligand validation:3HYX

PS9: octathiocane

PS9 is a Ligand Of Interest in 3HYX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3HYX_PS9_C_800	1%	48%	0.535	0.733	0.88	1.11	-	-	2	0	100%	0.3
3HYX_PS9_A_800	1%	30%	0.642	0.75	1.54	1.26	-	-	4	0	100%	0.2625
3HYX_PS9_D_800	0%	49%	0.62	0.688	0.81	1.15	-	-	4	0	100%	0.3
3HYX_PS9_F_800	0%	53%	0.701	0.731	0.86	0.96	-	-	1	0	100%	0.3
3HYX_PS9_E_800	0%	52%	0.774	0.677	0.86	0.99	-	-	3	0	100%	0.3
3HYX_PS9_B_800	0%	50%	0.743	0.603	0.83	1.09	-	-	3	0	100%	0.3
3HYV_PS9_A_800	1%	38%	0.442	0.659	0.9	1.53	-	2	2	0	100%	0.3
3HYW_PS9_F_800	1%	44%	0.504	0.647	0.87	1.27	-	-	2	0	100%	0.3
5JR5_PS9_A_101	70%	54%	0.103	0.919	1.07	0.71	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.